In another study, p53 was shown to regulate the expression of some defective TRIM22 genes in breast cancer, and the lack of p53-mediated induction contributed to the downregulation of TRIM22 (Sun et al., 2013; Li L. et al., 2018). The gene discussed is TRIM22; the disease is breast carcinoma.